Stocks
Arrowhead Pharmaceuticals (ARWR) EV/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EV/EBITDA | ? | -46.3 | -19.7 | -16.3 | -4.44 | 24.6 | -20.5 | |
| Changes by years, y/y, % | 0% | -58% | -17% | -73% | -655% | |||
Arrowhead Pharmaceuticals. EV/EBITDA
Arrowhead Pharmaceuticals. EV/EBITDA, changes, %
Arrowhead Pharmaceuticals (ARWR) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | LTM ? | |||
| EV/EBITDA | ? | -19.7 | -38.3 | 25.0 | 23.5 | -52.6 | -20.5 | |
| Changes by years, y/y, % | +154% | +499% | -655% | -611% | +167% | |||
| Changes by quarters, q/q, % | +329% | +94% | -165% | -6% | -324% | |||
